Nisa Investment Advisors, LLC Coherus Bio Sciences, Inc. Transaction History

Nisa Investment Advisors, LLC

  • $24.1 Billion
  • Q4 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 4,677 shares of CHRS stock, worth $6,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,677
Previous 4,014 16.52%
Holding current value
$6,501
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025
BUY
$0.67 - $1.71 $444 - $1,133
663 Added 16.52%
4,677 $6,000
Q3 2024

Oct 24, 2024
SELL
$0.99 - $1.8 $16,476 - $29,957
-16,643 Reduced 80.57%
4,014 $4,000
Q2 2024

Jul 19, 2024
BUY
$1.58 - $2.51 $31,460 - $49,979
19,912 Added 2672.75%
20,657 $35,000
Q1 2024

May 01, 2024
BUY
$2.02 - $3.14 $272 - $423
135 Added 22.13%
745 $1,000
Q4 2023

Jan 25, 2024
SELL
$1.59 - $3.85 $166 - $404
-105 Reduced 14.69%
610 $2,000
Q3 2023

Nov 02, 2023
BUY
$3.74 - $5.45 $205 - $299
55 Added 8.33%
715 $2,000
Q2 2023

Aug 11, 2023
BUY
$3.79 - $8.3 $94 - $207
25 Added 3.94%
660 $2,000
Q1 2023

May 02, 2023
BUY
$5.89 - $10.52 $147 - $263
25 Added 4.1%
635 $4,000
Q4 2022

Feb 02, 2023
SELL
$5.69 - $10.07 $398 - $704
-70 Reduced 10.29%
610 $5,000
Q3 2022

Nov 07, 2022
BUY
$7.17 - $13.87 $501 - $970
70 Added 11.48%
680 $6,000
Q2 2022

Aug 03, 2022
SELL
$5.86 - $13.23 $160,974 - $363,428
-27,470 Reduced 97.83%
610 $4,000
Q1 2022

Apr 29, 2022
SELL
$10.92 - $16.41 $2,730 - $4,102
-250 Reduced 0.88%
28,080 $363,000
Q4 2021

Feb 03, 2022
SELL
$15.81 - $18.99 $28,932 - $34,751
-1,830 Reduced 6.07%
28,330 $350,000
Q2 2021

Aug 06, 2021
BUY
$12.95 - $15.41 $27,195 - $32,361
2,100 Added 7.48%
30,160 $417,000
Q4 2020

Jan 25, 2021
BUY
$16.56 - $18.94 $14,075 - $16,099
850 Added 3.12%
28,060 $488,000
Q3 2020

Oct 20, 2020
BUY
$17.41 - $19.89 $40,043 - $45,747
2,300 Added 9.23%
27,210 $499,000
Q1 2020

Apr 17, 2020
BUY
$11.67 - $22.53 $1,400 - $2,703
120 Added 0.48%
24,910 $404,000
Q3 2019

Oct 17, 2019
BUY
$16.3 - $23.37 $2,934 - $4,206
180 Added 0.73%
24,790 $502,000
Q4 2018

Jan 17, 2019
SELL
$8.65 - $16.28 $34,600 - $65,120
-4,000 Reduced 13.98%
24,610 $223,000
Q3 2018

Oct 16, 2018
BUY
$14.45 - $20.25 $4,479 - $6,277
310 Added 1.1%
28,610 $472,000
Q4 2017

Jan 12, 2018
BUY
$8.35 - $14.4 $236,305 - $407,520
28,300
28,300 $249,000

Others Institutions Holding CHRS

# of Institutions
135
Shares Held
78M
Call Options Held
40.7K
Put Options Held
50.1K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $108M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email